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Abstract 
Present study was designed to evaluate the effect of Valsartan on renal marker, nitrite 
and histopathology of kidney in Ischemia/reperfusion induced renal damage in diabetic 
rats. Ischemia/reperfusion injury, which is commonly seen in the field of renal surgery 
or transplantation in diabetic condition, is a major cause of acute renal failure. Type 2 
Diabetes was induced in rats by a single intraperitoneal (i.p) injection of Streptozotocin 
(65 mg/kg, STZ) in overnight fasting rats followed by the i.p administration of 
Nicotinamide (110 mg/kg, NIC) after 15 minutes. After right nephrectomy, Valsartan 
(8 mg/kg/day, p.o) was administered for 15 days. On the 16th day, ischemia was 
induced in contra lateral kidney for 45 min, followed by reperfusion for 24 hr. Renal 
function marker and histopathology were estimated at the end of 24 hr reperfusion. At 
the end of experimental period the level of nitrite in kidney tissue, serum marker 
Albumin and Blood urea nitrogen were significantly changed. Valsartan improved the 
renal dysfunction and nitrite after renal ischemia/reperfusion injury in diabetic rats. 
Light microscopic evaluation of the kidneys of the diabetic rats with I/R only showed 
tubular cell swelling, interstitial edema, tubular dilatation, and moderate to severe 
necrosis, whereas, Valsartan improve tubular dilation, loss of interstitial hemorrhage, 
and glomerular atrophy. In conclusion, Valsartan as a beneficial agent on renal marker, 
nitrite and histopathology of kidney in Ischemia/reperfusion induced renal damage in 
diabetic rats.  
 
1. Introduction 
Ischemic injury to brain, heart, and kidney is 
associated with high morbidity and mortality. 
Improving the ability of these organs to tolerate 
ischemic injury would have important implications. 
Ischemic insults are often recurrent in diabetic 
patients. In the setting of loss of renal blood flow 
autoregulation that characterizes the post-ischemic 
kidney [1], Renal ischemia/reperfusion (I/R) injury 
is a major cause of acute renal failure (ARF) [2], 
which is faced in many clinical situations such as 
kidney transplantation, partial nephrectomy, renal 
artery, angioplasty, aortic aneurysm surgery, and 
elective urological operations. In these conditions, 
I/R injury initiates a complex and interrelated 
sequence of events, resulting in injury to and the 
eventual death of renal cells [3, 4]. Several factors 
have been implicated in the pathophysiological 
changes occurring while renal I/R injury including 
vascular or microvascular injury, endothelial 
dysfunction, accelerated cell necrosis, granulocyte 
activation, and modulation of nitric 
oxide/angiotensin II axis [5, 6].  
The rennin-angiotensin system plays a pivotal 
role in regulation of blood pressure. Renin acts on 
angiotensinogen to form angiotensin I, which is 
converted to angiotensin II with the help of 
angiotensin-converting enzyme (ACE) [7]. 
Angiotensin II is an important mediator in kidney 
injury. Accumulating evidence suggests that 
angiotensin II stimulates intracellular formation of 
reactive oxygen species (ROS) such as the 
superoxide anion and hydrogen peroxide that leads 
to kidney damage [8]. 
Recent studies clearly indicate that nitric oxide 
is fundamentally involved in the regulation of renal 
hemodynamics and homeostasis [9]. Moreover, it 
has been shown that reactive oxygen species (ROS) 
increase in the areas of ischemia and reperfusion 
[10]. ROS avidly react with nitric oxide (NO) and 
produce highly reactive nitrogen species 
(peroxynitrite), which can lead to functional NO 
deficiency. Peroxynitrite is an important agent that 
causes lipid peroxidation of vascular membranes 
[11, 12]. Studies proved that functional deficiency 
of NO leads to increased renal sympathetic nerve 
activity and this sympathetic activation increases β 
receptor activities in the body [13]. In addition, 
studies have shown that the β adrenoceptor present 
in kidney were exclusively of the β 1 type [14]. 
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Recent evidence suggest that blockade of the 
rennin-angiotensin system ameliorates diabetes 
induced renal dysfunction. Because activation 
Valsartan (VAL) - Angiotensin II receptor (AT 1) 
blocker blocks the vasoconstrictor and aldosterone-
secreting effects of angiotensin II by selectively 
blocking the binding of angiotensin II to the AT1 
receptor in many tissues, such as vascular smooth 
muscles and the adrenal gland.  Angiotensin 
receptor antagonists are widely used as 
antihypertensive in diabetic and non diabetic 
patients. Valsartan is reported for its renoprotective 
activity in diabetic rats.  
The present study, we investigated Valsartan 
on renal marker and histopathology of kidney in 
Ischemia/reperfusion induced renal damage in 
diabetic rats, and other word effect of Valsartan on 
renal complication in I/R induced renal damage in 
diabetic rats. 
 
2. Materials and Methods 
Drugs and Chemicals 
Valsartan hydrochloride was obtained as a gift 
sample from Alembic Pharmaceuticals Pvt.  Ltd., 
Baroda, India. STZ and NIC were obtained from 
SIGMA, St. Louis, MO, USA. All other chemicals 
and reagents used in the study were of analytical 
grade.  
 
Experimental Animals 
All experiments and protocols described in 
present study were approved by the Institutional 
Animal Ethics Committee (IAEC) of Dharmaj 
Degree Pharmacy College, Anand. Sprague Dawley 
rats (210 ± 15 g) were housed in-group of 3 
animals per cage and maintained under 
standardized laboratory conditions (12- h 
light/dark cycle, 24C) and provided free access to 
palleted CHAKKAN diet (Nav Maharashtra Oil 
Mills Pvt., Pune) and purified drinking water ad 
libitium. The animal experiment was approved by 
Animal Ethical Committee of the Institute 
(1163/a/08/CPCSEA). 
 
Experimental Induction of Type 2 Diabetes in 
Rats  
Type 2 Diabetes was induced in rats by a single 
intraperitoneal (i.p) injection of Streptozotocin (65 
mg/kg, STZ) in overnight fasting rats or mice 
followed by the i.p administration of Nicotinamide 
(110 mg/kg, NIC) after 15 minutes. STZ was 
dissolved in citrate buffer (pH 4.5) and NIC was 
dissolved in normal saline. After 7 days following 
STZ and NIC administration, blood was collected 
from retro-orbital puncture and serum samples 
were analyzed for blood glucose [15].  Animals 
showing fasting blood glucose higher than 250 
mg/dL were considered as diabetic and used for 
the further study.  
Experimental Protocol 
The rats were divided into three groups each 
consisting of six animals: 
Group 1: Animals served as sham-operated 
(underwent all surgical procedures 
without ischemia reperfusion).   
Group 2: After right nephrectomy on day 1, vehicle 
(0.5 % sodium CMC) was administered 
for 15 days; on day 16, ischemia was 
produced in the left kidney for 45 min, 
followed by reperfusion of 24 hr (I/R 
control). 
Group 3: After right nephrectomy on day 1, 
Valsartan (8 mg/kg/day, p.o.) was 
administered for 15 days; on day 16, 
ischemia was produced in the left 
kidney for 45 min, followed by 
reperfusion of 24 hr (I/R + VAL). 
 
Surgical Procedure 
The progress of the experiment 
Day 1 
Day 15 
Day 16 
Day 17 
Unilateral right nephrectomy 
Treatment 
45 minutes ischemia (left kidney) 
24 hr reperfusion 
Right nephrectomy was performed through a 
right flank incision (2 cm) under general anesthesia, 
ketamine (100 mg/kg, i.p.). After right 
nephrectomy, several treatments were given as 
mentioned previously for 15 days. On day 16, 
ischemia was produced in the left kidney by 
performing a left flank incision and dissecting the 
left renal pedicle to expose the renal vessels. Non 
traumatic vascular clamps were used to stop blood 
flow (in artery and vein) for 45 min. Reperfusion 
was established by removing the clamp after 45 min 
ischemia. The abdominal wall (muscular layer and 
skin) was closed with 4.0 mononylon suture. At the 
end of reperfusion period (after 24 hr), blood 
samples were collected and used for the estimation 
of renal function (BUN and creatinine). The 
abdomen was opened, and the kidneys were 
harvested for the biomarkers of oxidative stress. 
 
Characterization of Type 2 Diabetes Model 
Type 2 diabetes was confirmed by measuring 
fasting serum glucose using standard diagnostic kit 
(SPAN diagnostics Pvt., India) and the degree of 
uncontrolled diabetic state was confirmed by 
measuring HbA1c  (Ion Exchange Resin method). 
After seven day, diabetes was confirmed by 
measuring glucose and HbA1c as mentioned above. 
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Estimation of kidney function marker  
Blood was collected from the rats by retro-
orbital puncture at the time of sacrify and was 
allowed to clot for 10 minutes at room temperature. 
Clots were centrifuged at 2500 rpm for 10 minutes 
to separate the serum. Blood urea nitrogen level 
was measured by assay kits (SPAN Diagnostics Pvt. 
India) and Serum Albumin levels were measured by 
assay kits (Crest Biosystems Ltd. India).  
 
Estimation of kidney Tissue Nitrite Levels 
The level of nitrite level was estimated by the 
method of Lepoivre et al. [16]. To 0.5 mL of tissue 
homogenate, 0.1 mL of sulphosalicylic acid was 
added and vortexed well for 30 minutes. The 
samples were then centrifuged at 5,000 rpm for 15 
minutes. The protein-free supernatant was used for 
the estimation of nitrite levels. To 200 μL of the 
supernatant, 30 μL of 10% NaOH was added, 
followed by 300 μL of Tris-HCl buffer and mixed 
well. To this, 530 μL of Griess reagent was added 
and incubated in the dark for 10–15 minutes, and 
the absorbance was read at 540 nm against a Griess 
reagent blank. Sodium nitrite solution was used as 
the standard. The amount of nitrite present in the 
samples was estimated from the standard curves 
obtained.  
 
Histopathology 
For light microscopic evaluation, kidneys were 
fixed in 10% phosphate buffered formalin. 
Paraffin-embedded specimens were cut into 6 mm-
thick sections and stained with hematoxylin and 
eosin (H&E). The kidneys were examined under a 
light microscope (Olympus Bioxl) for the presence 
of tubular changes and interstitial inflammatory cell 
infiltration by an observer blinded to the animal 
treatment group.  
 
Statistical Analysis 
All of the data are expressed as mean ± SEM. 
Statistical significance between more than two 
groups was tested using one-way ANOVA 
followed by the Bonferroni multiple comparisons 
test or unpaired two-tailed student’s t-test as 
appropriate using a computer-based fitting program 
(Prism, Graphpad 5). Differences were considered 
to be statistically significant when p < 0.05. 
3. Results 
Characterization of Type 2 Diabetes 
Single intraperitoneal (i.p) injection of 
Streptozotocin (65mg/kg) followed by i.p 
administration of Nicotinamide (110 mg/kg) to rats 
produced severe hyperglycemia and increased 
HbA1c in 70 to 80 % the animals (Table 1). 
 
Table 1. Effect of Streptozotocin (65mg/kg/day, p.o) and Nicotinamide (110 mg/kg/day, p.o) on serum glucose and HbA1c 
changes level in rats. 
Groups Glucose HbA1c 
CON 101.8 ± 6.799 5.455 ± 0.3729 
STZ + NIC 332.8 ± 9.167*** 9.900 ± 0.6323*** 
Values are expressed as mean ± SEM for six animals in the group. ***P<0.001 
considered statistically significant as compared to respective Control group. 
 
Effect of VAL on kidney function marker 
The six rats which underwent renal I/R 
exhibited a significant increase in the serum 
concentrations of Albumin (1.950 ± 0.1746 mg/dL 
tissue, p<0.001, n = 6) and blood urea nitrogen 
(66.55 ± 3.32 mg/dL tissue, p<0.001, n = 6) 
compared with the sham control animals (4.133 ± 
0.1532, 25.96 ± 3.396 mg/dL tissue, respective 
Sham control, p<0.001, n = 6), suggesting a 
significant degree of glomerular dysfunction 
mediated by renal I/R. In I/R+VAL treated 
diabetic rats, serum Albumin and blood urea 
nitrogen levels were significantly (3.094 ± 0.3227, 
25.96 ± 3.396 mg/dL tissue, respective Sham 
control p<0.01, p<0.01, Respective Sham control, 
n = 6) higher as compared to I/R control group 
alone (Fig.1). 
 
 
Effect of VAL on kidney Tissue Nitrite Levels 
Renal I/R resulted in a significant decrease in 
the tissue levels of nitrite (127.5±7.68 nmol/gm 
tissue, p<0.05, n = 6) as compared to values 
obtained from the tissue of sham-operated animals 
(156.5 ± 9.68, n = 6). In I/R+VAL treated rats, a 
significant increase in the tissue levels of nitrite as 
compared to I/R control group alone (from 
127.5±7.68 to 170.6±9.72 nmol/gm tissue, p<0.05, 
n = 6) (Fig.2). 
 
Histopathological Analysis 
Light microscopic evaluation of the sham-
operated groups revealed a regular morphology of 
renal parenchyma with well-designated glomeruli 
and tubuli (Fig. 3). The sham control group of rats 
did not show any morphological changes. By 
contrast, the kidneys of the diabetic rats with I/R 
only showed tubular cell swelling, interstitial edema, 
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tubular dilatation, and moderate to severe necrosis, 
whereas, Valsartan Reduced tubular dilation, loss of 
interstitial hemorrhage, and glomerular atrophy 
were the regenerated features (Fig. 3). 
 
 
Figure 1. Effect of Valsartan (8 mg/kg/day, p.o) on serum Albumin (A) and Blood Urea Nitrogen (B) in the diabetic rats exposed 
to renal ischemia/reperfusion (I/R) injury. 
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Values are expressed as mean ± SEM for six animals in the group. * P<0.05, **P<0.01, ***P<0.001 considered statistically 
significant as compared to respective Sham group. A)***P<0.001 sham vs. I/R control, **P<0.01 I/R vs. I/R+VAL, B) ***P<0.001 
sham vs. I/R control, **P<0.01 I/R vs. I/R+VAL. 
 
4. Discussion 
The present study was under taken with the 
objective of exploring evaluate the effect of 
Valsartan as a beneficial agent in the treatment of 
Ischemia/reperfusion induced renal damage in 
diabetic rats. The transient discontinuation of renal 
blood supply is encountered in many clinical 
situations such as kidney transplantation, partial 
nephrectomy, renal artery angioplasty, aortic 
aneurysm surgery, and elective urological 
operations [3, 4]. This transient discontinuation 
causes renal I/R injury which results in decreased 
glomerular filtration and renal blood flow and 
increased urine output characterized by natriuresis 
and impaired concentrating ability. Acute renal 
failure produced by ischemia and reflow is 
histopathologically characterized by extensive 
tubular damage, tubular cell necrosis, glomerular 
injury, and signs of tubular obstruction with cell 
debris [17, 18]. 
Figure 2. Effect of Valsartan (8 mg/kg/day, p.o) on Tissue 
nitrate level in kidney tissue in diabetic rats exposed to renal 
ischemia/reperfusion (I/R) injury. 
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Values are expressed as mean ± SEM for six animals in 
the group. * P<0.05, **P<0.01, ***P<0.001 considered 
statistically significant as compared to respective Sham 
group. *P<0.05 sham vs. I/R control, *P<0.05 I/R vs. 
I/R+VAL. 
 
Figure 3. Morphological Changes Assessed by 
Histopathological Examination of Kidneys of diabetic Rats 
Exposed to Ischemia/Reperfusion (I/R) Injury With and 
Without Preceded Treatment with Valsartan (VAL) and 
Sham Operation. Sham: kidney section of a rat in the sham 
operation group shows normal glomeruli and tubuli, I/R: 
Kidney section of a rat exposed to bilateral renal 
ischemia/reperfusion shows severe interstitial hemorrhage 
surrounding the glomeruli and tubuli. Tubular epithelial 
degeneration is apparent, I/R+VAL: Kidney section of the 
rats with ischemia/reperfusion injury treated with Valsartan, 
in which slight degeneration of tubuli and glomeruli are seen. 
G = Glomerul, T = Tubuli. 
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In the clinical settings, renal I/R are a 
consequence of systemic hypoperfusion with 
subsequent circulatory resuscitation, such as 
following aortic cross-clamping or renal 
transplantation [19]. There is good evidence from 
both in vivo and in vitro studies that the formation 
of NO plays an important role in I/R [20]. One of 
the important mechanisms for I/R injury is 
excessive ROS, which scavenges NO and 
cumulates in reduced NO bioavailability [21]. 
Endothelial cells produce less bioactive NO in the 
presence of higher oxidative stress [22, 23]. 
In the present study, there was a significant 
decrease NO in I/R control group in comparison 
to the sham-operated group, A increase in NO level 
in the Valsartan-treated I/R+VAL group showed 
significant improvement in renal function as 
compared to the I/R control and I/R+VAL groups. 
Previous studies have shown that peroxynitrite 
level in the heart increases greater than 10-fold in 
the first minute of reperfusion [24]. In this study, 
there was a significant decrease in tissue nitrite 
levels in kidney of I/R group animals as compared 
to sham-operated group. Moreover, peroxynitrite 
could initiate lipid peroxidation, which damages the 
proximal tubular cells, nitration of tyrosine residues 
(nitro tyrosine), and nitration of cellular proteins, 
with a subsequent loss of protein structure resulting 
in reduction of the kidney function [25, 26]. Similar 
results were obtained in this study as well. There 
was a significant increase (3 fold) in the levels of 
serum BUN and significant decrease (3 fold) in the 
levels of serum albumin in I/R control group, 
whereas animals treated with VAL improve of renal 
function in comparison to I/R control group. 
 
5. Conclusions 
It is important to improve renal marker, nitrite 
and histopathology parameter to prevent renal I/R 
injury in diabetic condition. Our data support effect 
of Valsartan as a beneficial agent in renal 
complication in diabetic rats.  
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